ALTIMMUNE, INC. SC13G

Company

Altimmune, Inc.

Filed

February 2, 2018

Accession Number

0001393825-18-000012

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →